Cell-cycle inhibitors: three families united by a common cause.

Laboratory of Cell Cycle Regulation, Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Gene (Impact Factor: 2.08). 05/2000; 247(1-2):1-15. DOI: 10.1016/S0378-1119(00)00092-5
Source: PubMed

ABSTRACT In the cellular program leading to DNA synthesis, signals that drive cells into S-phase converge at the level of CDK activity. The products of at least three different gene families, Ink4, Cip/Kip and the pRb pocket-protein family, suppress S-phase entry. Ink4 proteins act by antagonizing the formation and activation of cyclin D-CDK4 complexes, of which the ultimate downstream target as related to S-phase entry appears to be pRb. Cip/Kip inhibitors impinge upon that pathway by inhibiting CDK2 kinases that participate in the inactivation of pRb and, like cyclin E, may also have roles independent of pRb. How the activities of these three classes of proteins are coordinated remains obscure. In recent years, development of mouse models has accelerated the elucidation of this complex network, showing roles that are sometimes cooperative and sometimes overlapping. We will discuss the interrelationships between Cip/Kip inhibitors and the components of the pRb pathway, and how their activities ultimately regulate cell proliferation.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: p16 is recognized as a tumor suppressor gene due to the prevalence of its genetic inactivation in all types of human cancers. Additionally, p16 gene plays a critical role in controlling aging, regulating cellular senescence, detection and maintenance of DNA damage. The molecular mechanism behind these events involves p16-mediated signaling pathway (or p16-Rb pathway), the focus of our study. Understanding functional dependence between dynamic behavior of biological components involved in the p16-mediated pathway and aforesaid molecular-level events might suggest possible implications in the diagnosis, prognosis and treatment of human cancer. In the present work, we employ reverse-engineering approach to construct the most detailed computational model of p16-mediated pathway in higher eukaryotes. We implement experimental data from the literature to validate the model, and under various assumptions predict the dynamic behavior of p16 and other biological components by interpreting the simulation results. The quantitative model of p16-mediated pathway is created in a systematic manner in terms of Petri net technologies.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Durante los últimos años, se ha acumulado evidencia que demuestra que la regulación del ciclo celular de las células es esencial para establecer tolerancia y suprimir autoinmunidad. Aunque la apoptosis se ha considerado un mecanismo importante en el control del desarrollo de tolerancia y autoinmunidad, la regulación del ciclo celular también constituye una vía alternativa en la prevención de la autoreactividad. Diferentes moléculas asociadas al ciclo celular actúan como supresoras de la autoinmunidad. Se ha demostrado recientemente que los inhibidores del ciclo celular p21 y p27 controlan la tolerancia de las células T, mientras que p21 también limita el desarrollo de la autoinmunidad. En esta revisión exploraremos los efectos de p21 y p27 en la inducción de la tolerancia de las células T y discutiremos la asociación entre pérdida de tolerancia y desarrollo de autoinmunidad en ratones p21–/–.
    Inmunologia 10/2007; 26(4):184-192. DOI:10.1016/S0213-9626(07)70088-4
  • [Show abstract] [Hide abstract]
    ABSTRACT: TGF-β plays a significant role in regulating pancreas islet function and maintaining their mass. KLF10, a TGF-β downstream gene, belongs to a group of Krüppel-like transcription factors that bind to the promoters of target genes and produce effects that mimic TGF-β as a tumor suppressor. Using ChIP-chip screening, SEI-1 was identified as a target gene that may be regulated by KLF10. We conducted a series of assays to verify the presence of unknown regulation events between SEI-1 and KLF10. These showed that KLF10 transcriptionally activates the SEI-1 promoter and, furthermore, induces SEI-1 protein expression in pancreatic carcinoma cells. SEI-1 is one of the key factors involved in cell cycle control through the regulation of other transcription factors such as the p21Cip1 gene. Interestingly, it has been shown previously that p21Cip1 is indirectly activated by KLF10. Our results first demonstrated that KLF10 acts as a transcriptional activator on SEI-1, which can then result in increased p21Cip1 expression. Furthermore, KLF10-deficiency in mice is associated with a decrease in the pancreatic islet mass, which is similar to the effects found in SEI-1 deficient mice. The KLF10-defect was also associated with the nuclear accumulation of the p21Cip1 in islet cells. Based on our molecular and histological findings, we conclude that KLF10 plays an important role in pancreatic β-cells and this supports a functional link between KLF10 and various cell cycle regulators, most notably in the context of the pancreas.
    The International Journal of Biochemistry & Cell Biology 01/2015; 60. DOI:10.1016/j.biocel.2014.12.021 · 4.24 Impact Factor

Full-text (3 Sources)

Available from
May 31, 2014